Eballena, Nena A.
HRN: 17-55-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2025
CEFTRIAXONE 1G (VIAL)
01/14/2025
01/20/2025
IV
2g
Od
Capmr
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes